Abstract
Biofilm producers pose a major challenge in treating implant-related orthopedic infections (IROIs). The incidence of IROIs for the closed fracture amounts to 1% to 2% whereas for open fracture it is up to 30%. Due to inappropriate and irrational use of antibiotics in the management of infections, there is an emergence of a global “antimicrobial resistance crisis”. To combat these antimicrobial resistance crises, a few innovative and targeted therapies like nanomedicine, phage therapy, antimicrobial peptides, and sonic therapies have been introduced. In this review, we have detailed the basic mechanisms involved in the employment of bacteriophage therapy for IROIs, along with the preclinical and clinical data on its utility. We also present the guidelines on its regulation, processing, and limitations of bacteriophage therpay to combat the upcoming era of antibiotic resistance.
Similar content being viewed by others
References
Steinmetz, S., Wernly, D., Moerenhout, K., Trampuz, A., & Borens, O. (2019). Infection after fracture fixation. EFORT Open Reviews, 4(7), 468–475. https://doi.org/10.1302/2058-5241.4.180093
Limoli, D. H., Jones, C. J., & Wozniak, D. J. (2015). Bacterial extracellular polysaccharides in biofilm formation and function. Microbiology Spectrum, 3(3), 3. https://doi.org/10.1128/microbiolspec.MB-0011-2014
Singh, S., Singh, S. K., Chowdhury, I., & Singh, R. (2017). Understanding the mechanism of bacterial biofilms resistance to antimicrobial agents. The Open Microbiology Journal, 11, 53–62. https://doi.org/10.2174/1874285801711010053
Sharma, D., Misba, L., & Khan, A. U. (2019). Antibiotics versus biofilm: An emerging battleground in microbial communities. Antimicrobial Resistance & Infection Control., 8(1), 76. https://doi.org/10.1186/s13756-019-0533-3
Lebeaux, D., Ghigo, J. M., & Beloin, C. (2014). Biofilm-related infections: Bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiology and Molecular Biology Reviews, 78(3), 510–543. https://doi.org/10.1128/MMBR.00013-14
Ventola, C. L. (2015). The antibiotic resistance crisis. Pharmacy and Therapeutics, 40(4), 277–283.
Aslam, B., Wang, W., Arshad, M. I., et al. (2018). Antibiotic resistance: A rundown of a global crisis. Infection and Drug Resistance, 11, 1645–1658. https://doi.org/10.2147/IDR.S173867
Dominey-Howes, D., Bajorek, B., Michael, C., Betteridge, B., Iredell, J., & Labbate, M. (2015). Applying the emergency risk management process to tackle the crisis of antibiotic resistance. Frontiers in Microbiology., 6, 927. https://doi.org/10.3389/fmicb.2015.00927
Laxminarayan, R., Duse, A., Wattal, C., et al. (2013). Antibiotic resistance-the need for global solutions. The Lancet Infectious Diseases, 13(12), 1057–1098. https://doi.org/10.1016/S1473-3099(13)70318-9
Gibb, B. P., & Hadjiargyrou, M. (2021). Bacteriophage therapy for bone and joint infections. The Bone & Joint Journal, 103-B(2), 234–244. https://doi.org/10.1302/0301-620X.103B2.BJJ-2020-0452.R2.
Tande, A. J., & Patel, R. (2014). Prosthetic joint infection. Clinical Microbiology Reviews, 27(2), 302–345. https://doi.org/10.1128/CMR.00111-13
Li, B., & Webster, T. J. (2018). Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections. Journal of Orthopaedic Research, 36(1), 22–32. https://doi.org/10.1002/jor.23656
Ribeiro, M., Monteiro, F. J., & Ferraz, M. P. (2012). Infection of orthopedic implants with emphasis on bacterial adhesion process and techniques used in studying bacterial-material interactions. Biomatter, 2(4), 176–194. https://doi.org/10.4161/biom.22905
Fair, R. J., & Tor, Y. (2014). Antibiotics and bacterial resistance in the 21st century. Perspectives in Medicinal Chemistry, 6, 25–64. https://doi.org/10.4137/PMC.S14459
Otto, M. (2009). Staphylococcus epidermidis—The “accidental” pathogen. Nature Reviews Microbiology, 7(8), 555–567. https://doi.org/10.1038/nrmicro2182
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019). Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: A review. Frontiers in Microbiology, 10, 539. https://doi.org/10.3389/fmicb.2019.00539
Gandra, S., Tseng, K. K., Arora, A., et al. (2019). The mortality burden of multidrug-resistant pathogens in India: A retrospective, observational study. Clinical Infectious Diseases, 69(4), 563–570. https://doi.org/10.1093/cid/ciy955
Karaiskos, I., Lagou, S., Pontikis, K., Rapti, V., & Poulakou, G. (2019). The, “Old” and the “New” antibiotics for MDR gram-negative pathogens: For whom, when, and how. Frontiers in Public Health, 7, 151. https://doi.org/10.3389/fpubh.2019.00151
Wittebole, X., De Roock, S., & Opal, S. M. (2014). A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence, 5(1), 226–235. https://doi.org/10.4161/viru.25991
Clokie, M. R., Millard, A. D., Letarov, A. V., & Heaphy, S. (2011). Phages in nature. Bacteriophage., 1(1), 31–45. https://doi.org/10.4161/bact.1.1.14942
Doss, J., Culbertson, K., Hahn, D., Camacho, J., & Barekzi, N. (2017). A review of phage therapy against bacterial pathogens of aquatic and terrestrial organisms. Viruses, 9(3), 50. https://doi.org/10.3390/v9030050
Lin, D. M., Koskella, B., & Lin, H. C. (2017). Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World Journal of Gastrointestinal Pharmacology and Therapeutics, 8(3), 162–173. https://doi.org/10.4292/wjgpt.v8.i3.162
Principi, N., Silvestri, E., & Esposito, S. (2019). Advantages and limitations of bacteriophages for the treatment of bacterial infections. Frontiers in Pharmacology, 10, 513. https://doi.org/10.3389/fphar.2019.00513
Loc-Carrillo, C., & Abedon, S. T. (2011). Pros and cons of phage therapy. Bacteriophage, 1(2), 111–114. https://doi.org/10.4161/bact.1.2.14590
Brady, T. S., Fajardo, C. P., Merrill, B. D., et al. (2018). Bystander phage therapy: Inducing host-associated bacteria to produce antimicrobial toxins against the pathogen using phages. Antibiotics, 7(4), 105. https://doi.org/10.3390/antibiotics7040105
Rosner, D., & Clark, J. (2021). Formulations for bacteriophage therapy and the potential uses of immobilization. Pharmaceuticals (Basel), 14(4), 359. https://doi.org/10.3390/ph14040359
Rotman, S. G., Sumrall, E., Ziadlou, R., et al. (2020). Local bacteriophage delivery for treatment and prevention of bacterial infections. Frontiers in Microbiology, 11, 538060. https://doi.org/10.3389/fmicb.2020.538060
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001). Bacteriophage therapy. Antimicrobial Agents and Chemotherapy, 45(3), 649–659. https://doi.org/10.1128/AAC.45.3.649-659.2001
Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013). Phage cocktails and the future of phage therapy. Future Microbiology, 8(6), 769–783. https://doi.org/10.2217/fmb.13.47
Hyman, P. (2019). Phages for phage therapy: Isolation, characterization, and host range breadth. Pharmaceuticals (Basel), 12(1), 35. https://doi.org/10.3390/ph12010035
Abedon, S. T. (2018). Phage therapy: Various perspectives on how to improve the art. Methods in Molecular Biology, 1734, 113–127. https://doi.org/10.1007/978-1-4939-7604-1_11
Gu Liu, C., Green, S. I., Min, L., et al. Phage-antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry. mBio, 11(4), e01462-20. https://doi.org/10.1128/mBio.01462-20
Zimecki, M., Artym, J., Kocięba, M., Weber-Dąbrowska, B., Borysowski, J., & Górski, A. (2009). Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus. BMC Microbiology, 9(1), 169. https://doi.org/10.1186/1471-2180-9-169
Zimecki, M., Artym, J., Kocieba, M., Weber-Dabrowska, B., Borysowski, J., & Górski, A. (2010). Prophylactic effect of bacteriophages on mice subjected to chemotherapy-induced immunosuppression and bone marrow transplant upon infection with Staphylococcus aureus. Medical Microbiology and Immunology, 199(2), 71–79. https://doi.org/10.1007/s00430-009-0135-4
Morris, J., Kelly, N., Elliott, L., et al. (2019). Evaluation of bacteriophage anti-biofilm activity for potential control of orthopedic implant-related infections caused by Staphylococcus aureus. Surgical Infections (Larchmt), 20(1), 16–24. https://doi.org/10.1089/sur.2018.135
Wroe, J. A., Johnson, C. T., & García, A. J. (2020). Bacteriophage delivering hydrogels reduce biofilm formation in vitro and infection in vivo. Journal of Biomedical Materials Research Part A, 108(1), 39–49. https://doi.org/10.1002/jbm.a.36790
Yilmaz, C., Colak, M., Yilmaz, B. C., Ersoz, G., Kutateladze, M., & Gozlugol, M. (2013). Bacteriophage therapy in implant-related infections: An experimental study. Journal of Bone and Joint Surgery American Volume, 95(2), 117–125. https://doi.org/10.2106/JBJS.K.01135
Kaur, S., Harjai, K., & Chhibber, S. (2016). In vivo assessment of phage and linezolid based implant coatings for treatment of methicillin resistant S. aureus (MRSA) mediated orthopaedic device related infections. PLoS One, 11(6), e0157626. https://doi.org/10.1371/journal.pone.0157626
Kishor, C., Mishra, R. R., Saraf, S. K., Kumar, M., Srivastav, A. K., & Nath, G. (2016). Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model. Indian Journal of Medical Research, 143(1), 87–94. https://doi.org/10.4103/0971-5916.178615
Meurice, E., Rguiti, E., Brutel, A., et al. (2012). New antibacterial microporous CaP materials loaded with phages for prophylactic treatment in bone surgery. Journal of Materials Science: Materials in Medicine, 23(10), 2445–2452. https://doi.org/10.1007/s10856-012-4711-6
Kaur, S., Harjai, K., & Chhibber, S. (2014). Bacteriophage mediated killing of Staphylococcus aureus in vitro on orthopaedic K wires in presence of linezolid prevents implant colonization. PLoS ONE, 9(3), e90411. https://doi.org/10.1371/journal.pone.0090411
Kolenda, C., Josse, J., Medina, M., et al. (2020). Evaluation of the activity of a combination of three bacteriophages alone or in association with antibiotics on Staphylococcus aureus embedded in biofilm or internalized in osteoblasts. Antimicrobial Agents and Chemotherapy, 64(3), e02231-e2319. https://doi.org/10.1128/AAC.02231-19
Barros, J., Melo, L. D. R., Poeta, P., et al. (2019). Lytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections. International Journal of Antimicrobial Agents., 54(3), 329–337. https://doi.org/10.1016/j.ijantimicag.2019.06.007
Fish, R., Kutter, E., Wheat, G., Blasdel, B., Kutateladze, M., & Kuhl, S. (2016). Bacteriophage treatment of intransigent diabetic toe ulcers: A case series. Journal of Wound Care, 25(Sup7), S27–S33. https://doi.org/10.12968/jowc.2016.25.Sup7.S27
Ferry, T., Boucher, F., Fevre, C., et al. (2018). Innovations for the treatment of a complex bone and joint infection due to XDR Pseudomonas aeruginosa including local application of a selected cocktail of bacteriophages. Journal of Antimicrobial Chemotherapy, 73(10), 2901–2903. https://doi.org/10.1093/jac/dky263
Onsea, J., Soentjens, P., Djebara, S., et al. (2019). Bacteriophage application for difficult-to-treat musculoskeletal infections: Development of a standardized multidisciplinary treatment protocol. Viruses, 11(10), 891. https://doi.org/10.3390/v11100891
Ferry, T., Leboucher, G., Fevre, C., et al. (2018). Salvage debridement, antibiotics and implant retention (“DAIR”) with local injection of a selected cocktail of bacteriophages: Is it an option for an elderly patient with relapsing Staphylococcus aureus prosthetic-joint infection? Open Forum Infectious Diseases, 5(11), ofy269. https://doi.org/10.1093/ofid/ofy269
Tkhilaishvili, T., Winkler, T., Müller, M., Perka, C., & Trampuz, A. (2019). Bacteriophages as adjuvant to antibiotics for the treatment of periprosthetic joint infection caused by multidrug-resistant Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 64(1), e00924-e1019. https://doi.org/10.1128/AAC.00924-19
LaVergne, S., Hamilton, T., Biswas, B., Kumaraswamy, M., Schooley, R. T., & Wooten, D. (2018). Phage therapy for a multidrug-resistant Acinetobacter baumannii craniectomy site infection. Open Forum Infectious Diseases, 5(4), ofy064. https://doi.org/10.1093/ofid/ofy064
Patey, O., McCallin, S., Mazure, H., Liddle, M., Smithyman, A., & Dublanchet, A. (2018). Clinical indications and compassionate use of phage therapy: Personal experience and literature review with a focus on osteoarticular infections. Viruses, 11(1), 18. https://doi.org/10.3390/v11010018
Nir-Paz, R., Gelman, D., Khouri, A., et al. (2019). Successful treatment of antibiotic-resistant, poly-microbial bone infection with bacteriophages and antibiotics combination. Clinical Infectious Diseases, 69(11), 2015–2018. https://doi.org/10.1093/cid/ciz222
Fish, R., Kutter, E., Bryan, D., Wheat, G., & Kuhl, S. (2018). Resolving digital Staphylococcal osteomyelitis using bacteriophage—A case report. Antibiotics (Basel)., 7(4), 87. https://doi.org/10.3390/antibiotics7040087
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors do not have any conflicts of interest to disclose.
Ethical standard
This article does not contain any studies with human or animal subjects performed by the any of the authors.
Informed consent
For this type of study informed consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jeyaraman, M., Jeyaraman, N., Konkathi, V.K. et al. Bacteriophage Therapy in Implant-Related Orthopedic Infections. JOIO 56, 1685–1693 (2022). https://doi.org/10.1007/s43465-022-00728-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43465-022-00728-y